Ruijin Hospital: Stomach Neoplasms trials

The registry lists 23 Stomach Neoplasms studies with Ruijin Hospital as lead sponsor. 10 are open to participants now and 1 have results posted.

Phase 1 5Phase 2 10Phase 3 3No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• LM-302 and S-1 Plus Intraperitoneal Paclitaxel With or Without Cadonilimab for Claudin 18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis: a Prospective, Exploratory StudyRecruitingNCT07556640Phase 2
• Non-Invasive Detection of claudin18.2 in Pancreatic and Gastric/Gastroesophageal Junction Cancer by [68Ga]Ga-NODAGA-SNA014 PET ImagingNot yet recruitingNCT07554742
• Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric CancerRecruitingNCT07366528Phase 3
• IBI343 Combined With Sintilimab Plus Chemotherapy in Gastric CancerRecruitingNCT07025889Phase 1/2
• Liposomal Irinotecan Combined with Sintilimab for Second-line Treatment of Progressive Gastric CancerNot yet recruitingNCT06697366Phase 2
• The Role of 18F-FDG&68Ga-FAPI PET/CT in the Assessment of Conversion Therapy Efficacy in Gastric Cancer with Peritoneal Metastasis.RecruitingNCT06597526
• Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal MetastasisRecruitingNCT06519591Phase 2
• Prediction of Neoadjuvant Chemotherapy Efficacy in Locally Advanced Gastric CancerRecruitingNCT05140746Not applicable
• ctDNA Screening in Advanced HER2 Positive Gastric CancerRecruitingNCT04520295
• Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric CancerNot yet recruitingNCT04384601Phase 3
• Dragon III: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric CancerCompletedNCT03636893Phase 2Results posted
• Development and Validation of the Surgical Assessment and Healthcare (SAH) Index for Gastric Cancer Treatment EvaluationCompletedNCT07180966
• In-hospital Outcomes of Older Patients With Gastric Cancer and Their Risk FactorsCompletedNCT06185907
• Effect of a Self-designed MET Exercise Intervention on Cancer-related Fatigue in Patients With Gastric CancerCompletedNCT05401045Not applicable
• Efficacy and Safety of Sintilimab Combined Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal MetastasisStatus unknownNCT05204173Phase 2
• Lenvatinib With Taxane Drugs Treatment for Advanced Gastric CancerStatus unknownNCT05171530Phase 1
• Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node MetastasisStatus unknownNCT05002686Phase 2/3
• Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric CancerStatus unknownNCT04781413Phase 1/2
• Human Albumin and Anastomotic Leakage After Gastric Cancer SurgeryCompletedNCT04490668
• Neoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC)Status unknownNCT04410887Phase 1/2
• Feasibility and Safety of Neoadjuvant Chemotherapy (FLOT ) for Gastric Cancer Patients in ChinaCompletedNCT03646591
• Escorting Octogenarian for Gastric Cancer SurgeryCompletedNCT03639792
• mFLOT Chemotherapy as First-line Treatment in GCCompletedNCT03606928Phase 1/2